The EPA has recently been facing criticism from industry and industry associations regarding long review times and increased fees. Find out why in this article.

Are the US and EU adopting similar approaches to regulating substances? We find out what these approaches are and why this is a significant change.

With growing evidence that continued exposure above specific levels to certain PFAS may lead to adverse health effects, experts across Canada and the US are working hard to answer critical questions about PFAS.

On 9 June 2020, the EPA issued direct final Significant New Use Rules (SNURs) for 16 substances, which were the subject of pre-manufacture notices (PMNs)